Elevation Oncology Analyst Ratings
JMP Securities Reiterates Market Outperform on Elevation Oncology, Maintains $7 Price Target
Elevation Oncology Analyst Ratings
Elevation Oncology Analyst Ratings
Elevation Oncology Analyst Ratings
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Amgen (AMGN) and Elevation Oncology (ELEV)
Elevation Oncology Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Elevation Oncology (ELEV), Moderna (MRNA)
Wedbush Sticks to Its Buy Rating for Elevation Oncology (ELEV)
Elevation Oncology Analyst Ratings
Promising Preclinical Data and Positive Phase 2 Results Bolster Buy Rating for Elevation Oncology
Analysts Offer Insights on Healthcare Companies: Adaptimmune Therapeutics (ADAP), Elevation Oncology (ELEV) and AC Immune SA (ACIU)
Elevation Oncology (ELEV) Receives a Buy From TD Cowen
Elevation Oncology Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Elevation Oncology (ELEV) and OrthoPediatrics (KIDS)
Elevation Oncology Analyst Ratings
Optimistic Buy Rating for Elevation Oncology on EO-3021's Promising Clinical Advancements and Differentiation
Elevation Oncology Analyst Ratings
Wedbush Reiterates Outperform on Elevation Oncology, Maintains $5 Price Target
Elevation Oncology Analyst Ratings